- June 12, 2024
Invitation to the lecture of Prof. Lakhal-Littleton
We kindly invite you to a lecture by Prof. Samira Lakhal-Littleton from the University of Oxford, a distinguished researcher, and expert, who will be
- May 12, 2024
Reimbursement of commuting costs
In response to the investigator’s suggestions, the Sponsor has been allowed to fund reimbursement of patient travel expenses. Grim Farm Ltd. has been contracted
- April 30, 2024
500 patients in the INFERRCT trial
Thanks to the commitment of the Investigators and Study Personnel on sites, more than 500 patients have already been enrolled in the INFERRCT trial.
- May 12, 2024
Reimbursement of commuting costs
In response to the investigator’s suggestions, the Sponsor has been allowed to fund reimbursement of patient travel expenses. Grim Farm Ltd. has been contracted to handle the billing. Shortly, a Grim Farm representative will contact you to provide a package of personal forms, a reimbursement form and the necessary
- April 30, 2024
500 patients in the INFERRCT trial
Thanks to the commitment of the Investigators and Study Personnel on sites, more than 500 patients have already been enrolled in the INFERRCT trial. Currently, recruitment is administered at 34 sites in Poland, and several more are waiting to be launched or awaiting for the enrollment of the first
- August 25, 2023
200 patients in INFERRCT trial
We are pleased to announce that more than 200 patients have already been successfully recruited in the non-commercial INFERRCT trial. We sincerely thank all the Investigators for their enthusiasm, commitment, and effective cooperation. We maintain our willingness to support you in the belief that only together we have the
- September 22, 2022
First patient
The commitment and hard work of teams from the Wroclaw Medical University and the University Clinical Hospital in Wroclaw has resulted in the achievement of one of the key milestones in the INFERRCT clinical trial. On Thursday, September 22, 2022, the first patient in the non-commercial INFERRCT clinical trial
- August 11, 2022
